| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |